Literature DB >> 29408325

Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients?

Ian McHardy1, Anna Romanelli2, Linda J Harris3, Glenn Opp2, Reggie Gaudino4, Anthony Torres4, Christopher R Polage2, Joseph M Tuscano5, George R Thompson6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29408325     DOI： 10.1016/j.jinf.2018.01.010

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  3 in total

1.  Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016.

Authors:  Kaitlin Benedict; George R Thompson; Brendan R Jackson
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

2.  Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Orbitrap High-Resolution Mass Spectrometry for Multi-Residue Analysis of Mycotoxins and Pesticides in Botanical Nutraceuticals.

Authors:  Alfonso Narváez; Yelko Rodríguez-Carrasco; Luigi Castaldo; Luana Izzo; Alberto Ritieni
Journal:  Toxins (Basel)       Date:  2020-02-12       Impact factor: 4.546

Review 3.  Current Landscape of Coccidioidomycosis.

Authors:  Ryan Boro; Prema C Iyer; Maciej A Walczak
Journal:  J Fungi (Basel)       Date:  2022-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.